Press Releases

Date Title
5 Mar. 2026 Alliance for Genomic Discovery expands with Regeneron Genetics Center membership and new proteomics data offering
27 Feb. 2026 Illumina whole-genome sequencing technology to accelerate rare disease testing in Florida
25 Feb. 2026 Illumina partners go beyond the genome, driving cancer breakthroughs using spatial transcriptomics, epigenomics, and proteomics
24 Feb. 2026 Illumina launches TruPath Genome, setting a new standard in genomic insight
23 Feb. 2026 Illumina unveils roadmap of groundbreaking NovaSeq X advancements in data quality, output, speed, and flexibility
17 Feb. 2026 Illumina To Webcast Upcoming Investor Conference
5 Feb. 2026 Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2025
3 Feb. 2026 Illumina and the San Diego Zoo Wildlife Alliance partner to sequence the Frozen Zoo®, supporting critical conservation genetics efforts globally
30 Jan. 2026 Illumina completes acquisition of SomaLogic
20 Jan. 2026 Illumina secures CMS reimbursement for TruSight™ Oncology Comprehensive, expanding access to precision oncology
13 Jan. 2026 Illumina introduces Billion Cell Atlas to accelerate AI and drug discovery
13 Jan. 2026 Illumina Announces Preliminary Unaudited Financial Results for Fourth Quarter and Fiscal Year 2025
12 Jan. 2026 Illumina to Announce Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 5, 2026
8 Jan. 2026 Illumina Appoints Dr. Eric Green as Chief Medical Officer
6 Jan. 2026 Illumina launches powerful software for connected, intuitive, and scalable multiomic analysis